Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Woman grasping her shoulder

The GRASP (Getting it Right: Addressing Shoulder Pain) trial compared a comprehensive supervised physiotherapy exercise programme versus a single session of best practice physiotherapy advice, with or without corticosteroid injection, in adults with a rotator cuff disorder.

Rotator cuff disorders are one of the most common causes of shoulder pain, accounting for around 70% all shoulder conditions. People with rotator cuff disorders often experience significant shoulder pain and impaired function. Treatment options include rest, advice, medication, exercise, manual therapy, and corticosteroid injections. However, use of these treatments can be highly variable. There is also considerable uncertainty around their effectiveness, mode of delivery and possible long-term harm.

Read the full news story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website

Similar stories

New computational technique reveals changes to lung function post COVID-19 infection

A new study led by Oxford researchers found that prior COVID-19 infection was associated with more uneven inflation of the lungs during normal breathing, smaller lung volumes, and greater respiratory dead space.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Celebrating Childhood Cancer Awareness Month

September was Childhood Cancer Awareness Month, and researchers in Department of Paediatrics took action to help raise awareness for this cause.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.